Shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Free Report) rose 12,207.7% during trading on Thursday . The company traded as high as $0.6435 and last traded at $0.64. Approximately 1,553 shares were traded during mid-day trading, a decline of 35% from the average daily volume of 2,381 shares. The stock had previously closed at $0.0052.
Ampio Pharmaceuticals Stock Performance
The firm has a market capitalization of $207,818.50, a P/E ratio of -0.02 and a beta of 5.96. The stock’s 50 day simple moving average is $0.19 and its 200 day simple moving average is $0.11.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc is a clinical?stage biopharmaceutical company focused on developing therapies that modulate the body’s inflammatory response to alleviate pain and improve functional outcomes. Headquartered in Englewood, Colorado, the company leverages proprietary plasma?derived and synthetic formulations to target chronic musculoskeletal and cardiovascular conditions.
The company’s lead product candidate, Ampion, is a novel, low?molecular?weight fraction of human serum albumin designed as a single intra?articular injection for patients suffering from osteoarthritis of the knee.
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due
- Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches
- Dollar at a 3-Year Low: 3 Exporters Quietly Printing Money
- Water Infrastructure: Why This Boring Sector Could Get Exciting
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
